| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.005 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.091 | 0.006 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.008 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.14 | 0.009 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.01 |